Serious Safety Warnings Both medications carry serious warnings
These factors included major adverse cardiac events, hypoglycemia, gastrointestinal adverse events, episodes of nausea, vomiting, or diarrhea, and changes in glycated hemoglobin (HbA1c), body weight, blood pressure, heart rate, and estimated glomerular filtration rate
Scientists had long known that loss of McSC causes hair graying
GLP-1RA treatment was associated with a significant reduction in MACE compared with placebo (HR 0.86, 95% CI 0.810.92)
How Tirzepatide Dose Escalation Works in Clinical Practice Most tirzepatide treatment plans begin with a low starting dose and gradually increase over weeks or months
Researchers at Olio Labs combined Truvetas real-world electronic health record (EHR) data, pre-clinical rodent models, and single-cell RNA sequencing to explore sex-based differences in GLP-1 drug tolerability